DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

DCM Shriram Fine Chemicals Limited — Outcome of Board Meeting

NSE 1 hr ago·14 Aug 2026, 8:22 am

DCM Shriram

DCM Shriram Fine Chemicals has announced its financial results for the period ending June 30, 2026, following a board meeting. The company has submitted these details to the stock exchange, providing an update on its financial performance during this specific quarter.

For investors, this update is significant as it offers a snapshot of the company's operational health and financial trajectory. Analyzing these results helps gauge the company's current standing and its ability to generate value in the competitive fine chemicals sector.

Investors should pay close attention to the specific financial metrics, such as revenue growth, profit margins, and any commentary on future outlook. These details will be crucial for understanding the company's performance and planning future investment strategies.